<DOC>
	<DOCNO>NCT01471223</DOCNO>
	<brief_summary>The purpose study estimate incidence rate Post-transplant Lymphoproliferative Disorder ( PTLD ) , malignancy hospitalize infection adult kidney-only transplant recipient treat Belatacept , compare incidence incidence treat Calcineurin inhibitor ( CNI ) base regimens time transplantation .</brief_summary>
	<brief_title>Belatacept Renal Transplantation : Analyses Using Data From Collaborative Transplant Study</brief_title>
	<detailed_description>Time Perspective : Prospective design , Retrospective data collection analysis</detailed_description>
	<mesh_term>Abatacept</mesh_term>
	<criteria>1st kidney transplant study , one transplant center participate CTS , receive Belatacept CNI time transplantation Patients history malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>